(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ENSPYRE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ENSPYRE

ST13

US500000097133570

Class

1, 5

Filing

97133570

Registration

6953079

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

01/17/2023

Classification

Registered

Trademark type

Word

Nice classes

1, 5

Filing date

11/19/2021

Registration date

01/17/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/17/2023

Last transaction

01/17/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Cambridge, GB

Examiner

TANNER, MICHAEL R

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Biofidelity Limited

Representatives

Ben Natter

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic preparationsother than for medical or veterinary purposes; Reagents for scientific or medical research usenamely reagents for preparation of nucleic acid samples prior to analysis and reagents for preparation of nucleic acid samples prior to sequencing; Cells for scientificlaboratory or medical research; Assays and reagents for use in genetic research; Reagents for use in scientific apparatus for chemical or biological analysis; Diagnostic preparations for clinical or medical laboratory use; Laboratory chemicalsreagents for use in the analysis and identification of nucleic acids and nucleic acid sequencesinfectious agents and pathogens for scientific or medical research use; kits containing assays that use reagents and chemical preparations to conduct molecular testing and analysis of biological samples for scientific and medical research purposes; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes

Class 5

Medical diagnostic reagents and assays for testing of body fluids; Preparations for detecting genetic predispositions for medical purposes; Reagents for use in medical diagnostic genetic testing; Reagents for clinical or medical usenamely diagnostic medical reagents for preparation of nucleic acid samples prior to analysis and reagents for preparation of nucleic acid samples prior to sequencing; Diagnostic reagents for diagnosing cancer; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical use; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Immunoassay reagents for medical use; Diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans and animals

Publications

History of USPTO decisions and trademark events.

16 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/17/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/17/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/01/2022

PUBO

PUBLISHED FOR OPPOSITION

11/01/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/12/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/29/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

09/06/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/06/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

09/06/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/06/2022

DOCK

ASSIGNED TO EXAMINER

08/31/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/20/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/20/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/20/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/24/2021

NWAP

NEW APPLICATION ENTERED

11/23/2021

Continuous trademark protection

Get notified about every new filing that threatens ENSPYRE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.